This topic contains a solution. Click here to go to the answer
« previous next »

Author Question: The anesthesia modifier for a patient with a severe systemic disease is: a. P2. b. P1. c. P3. ... (Read 69 times)

haleyc112

  • Hero Member
  • *****
  • Posts: 600
on: Jun 27, 2018
The anesthesia modifier for a patient with a severe systemic disease is:
 
  a. P2.
  b. P1.
  c. P3.
  d. P4.

Question 2

The anesthesia modifier for a patient with a mild systemic disease is:
 
  a. P2.
  b. P1.
  c. P5.
  d. P4.


Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

efwsefaw

  • Sr. Member
  • ****
  • Posts: 351
Reply #1 on: Jun 27, 2018
Answer to Question 1

Answer: c

Answer to Question 2

Answer: a


haleyc112

  • Member
  • Posts: 600
Reply 2 on: Jun 27, 2018
Thanks for the timely response, appreciate it

apple

  • Member
  • Posts: 352
Reply 3 on: Yesterday
:D TYSM

« previous next »
 

Did you know?

Barbituric acid, the base material of barbiturates, was first synthesized in 1863 by Adolph von Bayer. His company later went on to synthesize aspirin for the first time, and Bayer aspirin is still a popular brand today.

Did you know?

Though methadone is often used to treat dependency on other opioids, the drug itself can be abused. Crushing or snorting methadone can achieve the opiate "rush" desired by addicts. Improper use such as these can lead to a dangerous dependency on methadone. This drug now accounts for nearly one-third of opioid-related deaths.

Did you know?

Less than one of every three adults with high LDL cholesterol has the condition under control. Only 48.1% with the condition are being treated for it.

Did you know?

Blood is approximately twice as thick as water because of the cells and other components found in it.

Did you know?

In 2012, nearly 24 milliion Americans, aged 12 and older, had abused an illicit drug, according to the National Institute on Drug Abuse (NIDA).

Nurse palpating the patient's brachial artery Nurse palpating the patient's brachial artery
Dopamine Transporters, Methamphetamine Abuse, and Parkinson’s Disease Dopamine Transporters, Methamphetamine Abuse, and Parkinson’s Disease
Patient Education Follow-up Plan Patient Education Follow-up Plan
A patient with Cushing’s syndrome (A) before and (B) after receiving treatment. Sharmyn McGraw A patient with Cushing’s syndrome (A) before and (B) after receiving treatment. Sharmyn McGraw
Systemic Antifungal Agents Systemic Antifungal Agents
Video: Immune responses Animation

For a complete list of videos, visit our video library